Overexpression of IRF7 increased IFN-β production and thus significantly enhanced NK cell activity, leading to cytolysis of prostate cancer target cells and exerting an inhibitory effect on bone metastasis of prostate cancer. This evidence concerns the gene IRF7 and prostate carcinoma.